NasdaqGS - Nasdaq Real Time Price • USD
Neogen Corporation (NEOG)
As of 3:03 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
| Low Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
| High Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
| Year Ago EPS | 0.14 | 0.11 | 0.56 | 0.46 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 224.75M | 228.85M | 912.21M | 937.56M |
| Low Estimate | 222.71M | 226.1M | 910.13M | 935.53M |
| High Estimate | 226.8M | 231.6M | 914.3M | 939.6M |
| Year Ago Sales | 241.81M | 231.1M | 822.45M | 912.21M |
| Sales Growth (year/est) | -7.10% | -1.00% | 10.90% | 2.80% |
Earnings History
| CURRENCY IN USD | 5/31/2023 | 8/31/2023 | 11/30/2023 | 2/29/2024 |
|---|---|---|---|---|
| EPS Est. | -0.03 | 0.12 | 0.14 | 0.14 |
| EPS Actual | 0.14 | 0.11 | 0.11 | 0.12 |
| Difference | 0.17 | -0.01 | -0.03 | -0.02 |
| Surprise % | 566.70% | -8.30% | -21.40% | -14.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.11 | 0.12 | 0.46 | 0.55 |
| 7 Days Ago | 0.11 | 0.12 | 0.46 | 0.55 |
| 30 Days Ago | 0.17 | 0.17 | 0.54 | 0.72 |
| 60 Days Ago | 0.17 | 0.18 | 0.54 | 0.77 |
| 90 Days Ago | 0.17 | 0.18 | 0.54 | 0.77 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (May 2024) | Next Qtr. (Aug 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NEOG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -21.40% | -- | -- | 1.50% |
| Next Qtr. | 9.10% | -- | -- | 12.10% |
| Current Year | -17.90% | -- | -- | 4.40% |
| Next Year | 19.60% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 10.00% | -- | -- | 10.97% |
| Past 5 Years (per annum) | -7.33% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Piper Sandler: Neutral to Neutral | 4/15/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 1/18/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 10/16/2023 |
| Maintains | Wells Fargo: Overweight to Overweight | 8/14/2023 |
| Initiated | Wells Fargo: Overweight | 6/16/2023 |
| Maintains | Piper Sandler: Neutral | 12/15/2022 |
Related Tickers
SHC Sotera Health Company
11.37
+0.40%
MTD Mettler-Toledo International Inc.
1,239.67
+0.55%
GH Guardant Health, Inc.
17.38
+1.28%
CRL Charles River Laboratories International, Inc.
229.74
+0.85%
NEO NeoGenomics, Inc.
14.31
+3.32%
MYGN Myriad Genetics, Inc.
18.20
+1.22%
QGEN Qiagen N.V.
41.58
+1.22%
ICLR ICON Public Limited Company
307.88
+2.60%
IDXX IDEXX Laboratories, Inc.
498.30
+1.85%
XGN Exagen Inc.
1.4000
0.00%